NEW YORK (GenomeWeb News) – Affymetrix's eBioscience business has sold its TrueBlot IP/Western blot product line to Rockland Immunochemicals for an undisclosed price.

The TrueBlot reagents are used in cancer, cell signaling, infectious disease, and other life sciences research to generate data in immunoprecipitation and Western blot experiments. Western blotting is performed to determine expression and quantitate target proteins in biological samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.